SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-144674
Filing Date
2022-05-09
Accepted
2022-05-09 12:55:17
Documents
50
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d329315d10q.htm   iXBRL 10-Q 655643
2 EX-31.1 d329315dex311.htm EX-31.1 10661
3 EX-31.2 d329315dex312.htm EX-31.2 10620
4 EX-32.1 d329315dex321.htm EX-32.1 5888
  Complete submission text file 0001193125-22-144674.txt   3114766

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20220331.xsd EX-101.SCH 28136
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mdgl-20220331_cal.xml EX-101.CAL 25195
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mdgl-20220331_def.xml EX-101.DEF 95518
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20220331_lab.xml EX-101.LAB 240600
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20220331_pre.xml EX-101.PRE 181091
44 EXTRACTED XBRL INSTANCE DOCUMENT d329315d10q_htm.xml XML 377080
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 22904148
SIC: 2834 Pharmaceutical Preparations